Dosing with recombinant factor viia based on current evidence.
D001777:Blood Coagulation / Q000187:drug effects*; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000209:etiology; D001791:Blood Platelet Disorders / Q000188:drug therapy; D002648:Child; D004305:Dose-Response Relationship, Drug; D005167:Factor VII / Q000008:administration & dosage*; D015942:Factor VIIa; D006467:Hemophilia A / Q000188:drug therapy*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D019106:Postoperative Hemorrhage / Q000188:drug therapy; D011994:Recombinant Proteins / Q000008:administration & dosage*; D014947:Wounds and Injuries / Q000150:complications / Q000188:drug therapy
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa